Emergence and Infectious Complications of Ciprofloxacin-Resistant Escherichia coli in Haematological Cancer Patients

1998 ◽  
Vol 17 (8) ◽  
pp. 591-592 ◽  
Author(s):  
M. G. J. van Kraaij ◽  
A. W. Dekker ◽  
E. Peters ◽  
A. Fluit ◽  
L. F. Verdonck ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Cancer Patients ◽  
Infectious Complications ◽  
Haematological Cancer

Emergence and infectious complications of ciprofloxacin-resistantEscherichia coli in haematological cancer patients

1998 ◽  
Vol 17 (8) ◽  
pp. 591-592 ◽  
Author(s):  
M. G. J. Kraaij ◽  
A. W. Dekker ◽  
E. Peters ◽  
A. Fluit ◽  
L. F. Verdonck ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Infectious Complications ◽  
Haematological Cancer

scholarly journals MICROBIOLOGICAL ANALYSIS OF BILE IN PATIENTS WITH BENIGN AND MALIGNANT BILIOPANCREATIC DISEASES AND ITS CONSEQUENCES

2016 ◽  
Vol 53 (3) ◽  
pp. 156-162 ◽  
Author(s):  
José Roberto ALVES ◽  
Rodrigo do Carmo SILVA ◽  
Sâmea Costa Pinheiro GUERRA ◽  
Tiago Tavares de FREITAS ◽  
Dyego Leandro Bezerra de SOUZA ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Cancer Patients ◽  
Infectious Complication ◽  
Infectious Complications ◽  
Microbiological Analysis ◽  
Postoperative Infectious Complication ◽  
Duodenal Papilla ◽  
Benign Diseases ◽  
Bile Samples ◽  
Microbiological Flora

ABSTRACT Background Bactibilia has several consequences to human health. Objetive Assessing the bile microbiology of patients with biliopancreatic diseases in order to identify bacteria and their possible infectious complications. Methods Retrospective study of 30 bile culture samples from patients with benign and malignant biliopancreatic diseases. The samples were assessed to set the bile microbiological flora and to search for its possible link with comorbidity, carcinogenesis and postoperative infectious complications. Results Thirty bile samples from patients at mean age ≈57.7 years, mostly female (n=18), were assessed. Bactibilia was found in 12 cases, mostly in patients with benign diseases (n=8), older than 50 years (n=23) and female (n=10). Adenocarcinoma of the duodenal papilla (n=9) and cholelithiasis (n=8) were the most common diseases. Escherichia coli (n=5) and Klebsiella sp (n=3) were predominantly found in patients with benign diseases; and Klebsiella sp (n=2) and Streptococcus sp (n=2) were prevalent in cancer patients. There were postoperative infectious complications in seven cases, five of them in bactibilia-associated patients (P=0.084). Conclusion Bactibilia was found in 12 samples and Escherichia coli and Klebsiella sp were most often identified in patients with benign diseases, as well as Streptococcus sp and Klebsiella sp in cancer patients. There was a trend of higher postoperative infectious complication incidence in patients with bactibilia.

Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines

2018 ◽  
Vol 76 (1) ◽  
pp. 20-37 ◽  
Author(s):  
Malgorzata Mikulska ◽  
Diana Averbuch ◽  
Frederic Tissot ◽  
Catherine Cordonnier ◽  
Murat Akova ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Critical Appraisal ◽  
Haematological Cancer ◽  
Fluoroquinolone Prophylaxis

scholarly journals INFECTIOUS COMPLICATIONS CAUSED BY NON-SPOREFORMING ANAEROBIC BACTERIA IN CANCER PATIENTS. RELEVANCE OF THE PROBLEM

2020 ◽  
Vol 19 (4) ◽  
pp. 146-151
Author(s):  
I. V. Tereshchenko ◽  
Z. V. Grigoryevskaya ◽  
I. N. Petukhova ◽  
N. S. Bagirova ◽  
V. D. Vinnikova ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Anaerobic Bacteria ◽  
Infectious Complications

scholarly journals The Optimal Time of Applying Enteral Immunonutrition in Esophageal Cancer Patients Receiving Esophagectomy: A Network Meta-Analysis of Randomized Clinical Trials

2021 ◽  
Author(s):  
Xu Tian ◽  
Yan-Fei Jin ◽  
Zhao-Li Zhang ◽  
Hui Chen ◽  
Wei-Qing Chen ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Cancer Patients ◽  
Randomized Clinical Trials ◽  
Meta Analysis ◽  
Infectious Complications ◽  
Cochrane Library ◽  
Optimal Time ◽  
Registration Number ◽  
Meta Analyses ◽  
The Impact

Abstract Background: Enteral immunonutrition (EIN) has been extensively applied in cancer patients, however its role in esophageal cancer (EC) patients receiving esophagectomy remains unclear. We performed this network meta-analysis to investigate the impact of EIN on patients undergoing surgery for EC and further determine the optimal time of applying EIN.Methods: We searched PubMed, EMBASE, Cochrane library, and China National Knowledgement Infrastructure (CNKI) to identify eligible studies. Categorical data was expressed as the odds ratio with 95% confidence interval (CI), and continuous data was expressed as mean difference (MD) with 95% CI. Pair-wise and network meta-analysis was performed to evaluate the impact of EIN on clinical outcomes using RevMan 5.3 and ADDIS V.1.16.8 softwares. The surface under the cumulative ranking curve (SUCRA) was calculated to rank all nutritional regimes.Results: Total 14 studies involving 1071 patients were included. Pair-wise meta-analysis indicated no difference between EIN regardless of the application time and standard EN (SEN), however subgroup analyses found that postoperative EIN was associated with decreased incidence of total infectious complications (OR=0.47; 95%CI=0.26 to 0.84; p=0.01) and pneumonia (OR=0.47; 95%CI=0.25 to 0.90; p=0.02) and shortened LOH (MD=-1.01; 95%CI=-1.44 to -0.57; p<0.001) compared to SEN, which were all supported by network meta-analyses. Ranking probability analysis further indicated that postoperative EIN has the highest probability of being the optimal option in terms of these three outcomes.Conclusions: Postoperative EIN should be preferentially utilized in EC patients undergoing esophagectomy because it has optimal potential of decreasing the risk of total infectious complications and pneumonia and shortening LOH.OSF registration number: 10.17605/OSF.IO/KJ9UY.

scholarly journals Bacteraemia due to extended-spectrum  -lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome

2009 ◽  
Vol 65 (2) ◽  
pp. 333-341 ◽  
Author(s):  
C. Gudiol ◽  
L. Calatayud ◽  
C. Garcia-Vidal ◽  
J. Lora-Tamayo ◽  
M. Cisnal ◽  
...  
Keyword(s):  
Risk Factors ◽  
Escherichia Coli ◽  
Molecular Epidemiology ◽  
Cancer Patients ◽  
Clinical Features ◽  
Extended Spectrum

scholarly journals Evaluation of cinnamon extract effects on clbB gene expression and biofilm formation in Escherichia coli strains isolated from colon cancer patients

BMC Cancer ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Faezah Kosari ◽  
Mohammad Taheri ◽  
Abbas Moradi ◽  
Reza Hakimi Alni ◽  
Mohammad Yousef Alikhani
Keyword(s):  
Gene Expression ◽  
Escherichia Coli ◽  
Colon Cancer ◽  
Cancer Patients ◽  
Biofilm Formation ◽  
Cinnamon Extract

Serum Procalcitonin Levels Are Elevated in Esophageal Cancer Patients with Postoperative Infectious Complications

2005 ◽  
Vol 37 (1) ◽  
pp. 22-28 ◽  
Author(s):  
S. Ito ◽  
N. Sato ◽  
M. Kojika ◽  
Y. Yaegashi ◽  
Y. Suzuki ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Cancer Patients ◽  
Infectious Complications

scholarly journals Prevalence of some virulence factors and genotyping of hospital-acquired uropathogenic Escherichia coli isolates recovered from cancer patients

2020 ◽  
Vol 23 ◽  
pp. 211-216
Author(s):  
Ahmed Talaat Mahmoud ◽  
Reham Ali Ibrahem ◽  
Mohamed Taha Salim ◽  
Adel Gabr ◽  
Hamada Mohamed Halby
Keyword(s):  
Escherichia Coli ◽  
Cancer Patients ◽  
Virulence Factors ◽  
Uropathogenic Escherichia Coli ◽  
Hospital Acquired

Improving the efficiency of the postoperative period in the surgical treatment cancer patients with metastatic bone fractures upper and lower extremities using elixir altai ("vitavis") in combination with ion-activated water resources

10.12737/6454 ◽  
2014 ◽  
Vol 8 (1) ◽  
pp. 0-0
Author(s):  
Антонов ◽  
A. Antonov
Keyword(s):  
Quality Of Life ◽  
Surgical Treatment ◽  
Postoperative Complications ◽  
Cancer Patients ◽  
Postoperative Period ◽  
Bone Fractures ◽  
Infectious Complications ◽  
Lower Limbs ◽  
Oncologic Patients

Use elixir Altai (&#34;Vitavis&#34;) in combination with ion-activated with water by means of such a complex contingent cancer patients as patients with metastatic bone fractures of the upper and lower limbs can reduce the early postoperative period, and to reduce to a minimum infectious complications and improve quality of life. The problem of postoperative complications, until now, is not solved. In oncologic patients, and those more in by III and As IV stages occurs it immunnodefitsit, which is caused not only by basic disease, but also by conse-quences of khimio- beam therapy. In connection with this appears the difficulty in the surgical treatment, caused by postoperative complications. As a result surgical treatment appears surgical injury, oxidizing stress, disturbance of homeostasis and oppression of immunity, which leads to an even larger disturbance of immunity in oncologic patients, which decreases the unspecific resistibility of organism. The application of adaptogena of the elixir of Altai (“Vitavis”) in combination with the ionic- activated aqueous means makes it possible to level and to reduce on no oxidizing stress, to increase the unspecific resistibility of the organism of oncologic patient and to increase immuni-ty. Moreover, powerful antioxidant - the ionic- activated aqueous means strengthens the action of adaptogena of the elixer of Altai (“Vitavis”), which leads to the decrease of postoperative infectious complications, reduces postoperative period, improves the quality of life and enlarges indications to the surgical treatment in oncologic patients with III it and IV by the stages of diseases.

Sign in / Sign up

Export Citation Format

Share Document